ctrl K

Watchlist Price Alert

Sigilon Therapeutics Inc. (SGTX)

NASDAQ: SGTX · Real-Time Price · USD

22.47

-0.59 (-2.56%)

At close: Aug 10, 2023, 8:00 PM

Sigilon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	42.07M	107.14M	202.23M	76.07M	64.1M
Short-Term Investments	27.56M	16.21M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.03M	1.12M	1.12M	641K	576K
Receivables	3.46M	59K	177K	136K	n/a
Inventory	250K	250K	75K	n/a	n/a
Other Current Assets	1.08M	2.73M	1.73M	732K	422K
Total Current Assets	74.41M	126.39M	204.21M	76.94M	64.53M
Property-Plant & Equipment	11.83M	16.86M	19.72M	12.8M	2.56M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.87M	17.98M	20.84M	13.44M	3.13M
Total Assets	87.28M	144.37M	225.05M	90.38M	67.67M
Account Payables	936K	2.34M	1.99M	2M	1.98M
Deferred Revenue	12.88M	17.03M	31.78M	29.14M	24.75M
Short-Term Debt	11.15M	6.51M	5.36M	3.38M	667K
Other Current Liabilities	6.02M	9M	7.89M	5.85M	1.81M
Total Current Liabilities	30.99M	34.89M	47.02M	40.38M	29.2M
Long-Term Debt	16.91M	26.99M	31.7M	21.68M	4.29M
Other Long-Term Liabilities	233K	n/a	176K	90.54M	59K
Total Long-Term Liabilities	17.14M	32.32M	31.88M	127.77M	74.56M
Total Liabilities	48.14M	67.21M	78.89M	168.14M	103.76M
Total Debt	28.06M	33.5M	37.06M	25.05M	4.96M
Common Stock	32K	32K	31K	5K	5K
Retained Earnings	-256.8M	-213.24M	-135.93M	-81.32M	-37.4M
Comprehensive Income	-429K	-10K	-225.05M	n/a	-515K
Shareholders Equity	39.14M	77.16M	146.16M	-77.76M	-36.1M
Total Investments	27.56M	16.21M	n/a	n/a	n/a